Operating Lease, Right-of-Use Asset of Acorda Therapeutics, Inc. from 31 Mar 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Acorda Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Mar 2024.
  • Acorda Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2024 was $3,941,000, a 22% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Acorda Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $3,941,000 -$1,088,000 -22% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $4,221,000 -$1,066,000 -20% 31 Dec 2023 10-Q 14 May 2024 2024 Q1
Q3 2023 $4,496,000 -$1,045,000 -19% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $4,765,000 -$1,027,000 -18% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $5,029,000 -$587,000 -10% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $5,287,000 -$1,464,000 -22% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $5,541,000 -$2,320,000 -30% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $5,792,000 -$3,157,000 -35% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $5,616,000 -$4,397,000 -44% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $6,751,000 -$11,730,000 -63% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $7,861,000 -$11,944,000 -60% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $8,949,000 -$12,217,000 -58% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $10,013,000 -$12,437,000 -55% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $18,481,000 -$4,969,000 -21% 31 Dec 2020 10-K 18 Mar 2022 2021 FY
Q3 2020 $19,805,000 -$4,870,000 -20% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $21,166,000 -$4,710,000 -18% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $22,450,000 -$4,352,000 -16% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $23,450,000 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 $24,675,000 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $25,876,000 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $26,802,000 31 Mar 2019 10-Q 08 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.